Kyowa Kirin Co (TSE:4151) Total Liabilities : 円221,914 Mil (As of Mar. 2024)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Total Liabilities?

Kyowa Kirin Co's Total Liabilities for the quarter that ended in Mar. 2024 was 円221,914 Mil.

Kyowa Kirin Co's quarterly Total Liabilities declined from Sep. 2023 (円191,908.00 Mil) to Dec. 2023 (円189,524.00 Mil) but then increased from Dec. 2023 (円189,524.00 Mil) to Mar. 2024 (円221,914.00 Mil).

Kyowa Kirin Co's annual Total Liabilities declined from Dec. 2021 (円184,710.00 Mil) to Dec. 2022 (円177,055.00 Mil) but then increased from Dec. 2022 (円177,055.00 Mil) to Dec. 2023 (円189,524.00 Mil).

Kyowa Kirin Co Total Liabilities Historical Data

The historical data trend for Kyowa Kirin Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Total Liabilities Chart

Kyowa Kirin Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

106,203.00

102,894.00

184,710.00

177,055.00

189,524.00

Kyowa Kirin Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															163,851.00	184,905.00	191,908.00	189,524.00	221,914.00

Kyowa Kirin Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Kyowa Kirin Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	133237	+	(0	+	55994
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	293)
	=	189,524

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1025942	-	836418
	=	189,524

Kyowa Kirin Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	156557	+	(0	+	65013
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	344)
	=	221,914

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1065883	-	843969
	=	221,914

Kyowa Kirin Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines